-+ 0.00%
-+ 0.00%
-+ 0.00%
Novarex Corrects Third-Quarter Expenses to KRW 85.96 Billion From KRW 176.78 Billion
Share
Listen to the news
Novarex Corrects Third-Quarter Expenses to KRW 85.96 Billion From KRW 176.78 Billion
  • Novarex on Nov. 16 corrected expense figures in its third-quarter 2026 report, citing incorrectly entered amounts.
  • Quarterly expenses totaled KRW 85.96 billion, revised from KRW 176.78 billion.
  • Comparative third-quarter 2025 expenses were corrected to KRW 100.93 billion from KRW 188.97 billion.
  • Cumulative expenses remained unchanged at KRW 283.44 billion for 2026 and KRW 271.26 billion for 2025.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Novarex Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261116000988), on November 16, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending